Cellectis (CLLS) Exchange Rate Effect (2015 - 2026)
Cellectis' (CLLS) quarterly Exchange Rate Effect came in at -$217000.0 in Q1 2026, down 115.37% year-on-year from $1.4 million in Q1 2025, and down 116.19% quarter-over-quarter from $1.3 million in Q4 2025.
Cellectis (CLLS) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Cellectis' Exchange Rate Effect history runs 12 years deep, the most recent figure standing at -$217000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 115.37% year-over-year to -$217000.0 in Q1 2026; TTM through Mar 2026 was $2.3 million, a 314.26% increase from a year earlier, with the FY2025 full-year figure at $3.9 million, up 242.73% from the prior year.
- Exchange Rate Effect fell to -$217000.0 in Q1 2026 per CLLS's latest filing, from $1.3 million in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.0 million in Q4 2022 and bottomed at -$2.9 million in Q2 2022.
- The 5-year median for Exchange Rate Effect is -$217000.0 (2026), against an average of -$89235.3.
- Across the five-year window, Exchange Rate Effect slumped 798.33% in 2022 and soared 1164.12% in 2024, its largest moves.
- Year by year, Exchange Rate Effect stood at $2.0 million in 2022, then decreased by 14.36% to $1.7 million in 2023, then tumbled by 220.46% to -$2.1 million in 2024, then soared by 165.21% to $1.3 million in 2025, then plunged by 116.19% to -$217000.0 in 2026.
- Per Business Quant, the three latest CLLS Exchange Rate Effect figures stand at -$217000.0 (Q1 2026), $1.3 million (Q4 2025), and $1.7 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | -217,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -217,000.00 |
| Mar 31, 2026 | -217,000.00 |
| Dec 31, 2025 | 1.34 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | -529,000.00 |
| Jun 30, 2025 | -529,000.00 |
| Mar 31, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | -2.06 Mn |
| Dec 31, 2024 | -2.06 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Mar 31, 2024 | -267,000.00 |
| Mar 31, 2024 | -267,000.00 |
| Dec 31, 2023 | 1.71 Mn |
| Dec 31, 2023 | 1.71 Mn |